Multi-Attribute Method (MAM) offers an ideal solution for development and release of safe and effective biotherapeutics

Others | 2022 | Thermo Fisher ScientificInstrumentation
LC/HRMS, LC/MS, LC/MS/MS, LC/Orbitrap, Software
Industries
Proteomics , Pharma & Biopharma
Manufacturer
Thermo Fisher Scientific
Downloadable PDF for viewing
 

Similar PDF

Straight through to breakthrough Thermo Scientific MAM 2.0 Workflow
Straight through to breakthrough Thermo Scientific MAM 2.0 Workflow
2023|Thermo Fisher Scientific|Brochures and specifications
Deploying the multi-attribute method (MAM) across sites at Pfizer
The MAM 2.0 workflow enables seamless transition from research and development to quality control
Rich Rogers discusses his vision of what the future may hold for the multi-attribute method (MAM) in the biopharmaceutical industry